<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: January 22, 1996
NABI
---------------
(Exact name of registrant as specified in its charter)
Delaware 0-4829-03 59-1212264
----------------------- ----------- ------------------
(State of incorporation (Commission (IRS Employer
or organization) File Number) Identification No.)
5800 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487
----------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (407) 989-5800
--------------------------------------------------------------------
North American Biologicals, Inc.
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events.
-------------
On January 16, 1996, the following press release was issued in connection
with NABI's proposed issuance of convertible subordinated notes:
"North American Biologicals, Inc. (Nasdaq: NBIO) announced today that it
intends, subject to market and other conditions, to raise sixty million
dollars through the sale of convertible subordinated notes to certain
institutional investors and non-US investors and up to [an additional] nine
million dollars if an over-allotment option to be granted is exercised in
full. The notes will be convertible into NABI Common Stock.
The securities to be offered will not be registered under the Securities
Act of 1933, as amended, or applicable state securities laws, and may not
be offered or sold absent registration under the Securities Act and
applicable state securities laws or available exemptions from
registrations."
On January 17, 1996, the Company changed its name from North American
Biologicals, Inc. to NABI. Effective Thursday, January 18, 1996, the Company
changed the trading symbol for its Common Stock on the Nasdaq National Market
from "NBIO" to "NABI."
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
NABI
By: /s/ Alfred J. Fernandez
-------------------------------
Alfred J. Fernandez
Senior Vice President and
Chief Financial Officer
Date: January 22, 1996
-3-